E learning Medical Instructional Interactive Animations

Scientists Reveal Structure Of New Botulism Nerve Toxin Subtype
Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have determined the atomic-level structure of a third subtype of botulinum neurotoxin - a deadly toxin produced by certain bacteria that causes the disease botulism, and is also used in cosmetic and therapeutic applications such as reducing wrinkles and calming a hyperactive bladder.

New Book Focuses On Counter-Terrorism
The scourge of modern terrorism can be tackled more effectively by understanding how and why certain individuals give up their violent ways, according to a counter-terrorism expert who says information gleaned from ex-terrorists could provide clues to checking the growth of militant organizations. "Individuals do not necessarily join extremist groups because they hold extremist views," said John Horgan, director of Penn State's International Center for the Study of Terrorism.

Universal Detection Technology Receives Purchase Order For Its Anthrax Detection Equipment From The City Of Calgary, Canada Police Service
Universal Detection Technology (OTCBB: UNDT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has received a purchase order for its anthrax detection equipment from the city of Calgary, Canada Police Service.

DOR BioPharma Announces FDA Clearance Of IND For DOR201 In Radiation Enteritis
DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced today that the U.S.

Novel Histone Demethylase Protein Complex Discovered By Researchers At Stowers Institute's Workman Lab
The Stowers Institute's Workman Lab has discovered a novel histone demethylase protein complex characterized in work published in Molecular Cell. The Histone H3 protein is an important component of chromatin, the packing material wrapping up chromosomal DNA and preventing unwanted transcription of the message encoded in the DNA. Histone H3 can be altered by adding (methylating) or removing (demethylating) methyl groups from the histone protein.

New Study Indicates Smallpox Vaccination Effective For Decades
Although naturally occurring smallpox was eradicated in 1977, there is concern that bioterrorists might obtain smallpox from a laboratory and release it into the population. Under such circumstances, the supply of smallpox vaccine may be insufficient for universal administration.

The Government Of Canada Procures IMVAMUNE(R) Smallpox Vaccine For The Country's Biological Preparedness
Following a Request for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government Services Canada, on behalf of the Canadian Department of National Defence, has awarded a contract to Bavarian Nordic for the delivery of IMVAMUNE®. The Canadian authorities intend to use IMVAMUNE® as part of the country's bio-preparedness programme.

PS-Targeting Antibodies May Represent A New Class Of Drugs With Broad Potential To Treat Viral Infections
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) has reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

UT Southwestern Researchers Develop New Strategy For Broad Spectrum Anti-Viral Drugs
Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. In a study appearing in the December issue of Nature Medicine, groups of guinea pigs infected with a virus similar to Lassa fever virus recovered from the fatal disease when treated with bavituximab alone or in combination with a common anti-viral medication.

Aeolus Pharmaceuticals Initiates Pivotal Animal Study Of AEOL 10150 As A Countermeasure To Radiation Exposure
Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has initiated the first of two expected pivotal studies of AEOL 10150 as a countermeasure to nuclear and radiological exposure. The study, led by Zeljko Vujaskovic, M.D. Ph.D.

Final World Trade Center 7 Investigation Report Released By NIST
The National Institute of Standards and Technology (NIST) has released its final report on the Sept. 11, 2001, collapse of the 47-story World Trade Center building 7 (WTC 7) in New York City. The final report is strengthened by clarifications and supplemental text suggested by organizations and individuals worldwide in response to the draft WTC 7 report, released for public comment on Aug.

Investigations Following A Death From Anthrax
Following the announcement of the death of a patient from inhalation anthrax the Health Protection Agency have been carrying out testing at the patient's workshop in Hackney, where animal skin drums were made. Testing was carried out to see whether there were traces of anthrax at the property and if any specialist cleaning was needed before it could be used again.

"Powerhouses" From Living Cells Power New Explosives Detector - Journal Of The American Chemical Society
Researchers in Missouri have borrowed the technology that living cells use to produce energy to develop a tiny, self-powered sensor for rapid detection of hidden explosives. The experimental sensor, about the size of a postage stamp, represents the first of its kind to be powered by mitochondria, the microscopic "powerhouses" that provide energy to living cells, the researchers say. Their study is scheduled for the November 26 issue of the weekly Journal of the American Chemical Society.

Molecule That Stops SARS Invented By Purdue Researcher
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease. "The outbreak of SARS in 2003 led to hundreds of deaths and thousands of illnesses, and there is currently no treatment," said Arun Ghosh, the Purdue professor that led the molecular design team. "Although it is not currently a threat, there is the concern that SARS could return or be used as a biological weapon.

MAIL DEFENDER Now Available To Combat "White Powder" And Fake Anthrax Bio-Chemical Assaults
BioDefense Corporation, producers of the new MAIL DEFENDER complete mailroom security solution, is on the front lines of combating bio-chemical assaults. "Incoming mail containing white powder discovered on October 30, 2008 at the Boston Herald, Christian Science Monitor and more than 100 media offices across the country are not 'hoaxes.